|
Volumn 19, Issue 2, 2007, Pages 63-68
|
Bivalirudin versus heparin plus glycoprotein IIb/IIIa inhibitors in drug-eluting stent implantations in the absence of acute myocardial infarction: clinical and economic results.
a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ABCIXIMAB;
ANTICOAGULANT AGENT;
DRUG DERIVATIVE;
EPTIFIBATIDE;
FIBRINOGEN RECEPTOR;
HEPARIN;
HIRUDIN DERIVATIVE;
HIRULOG;
IMMUNOGLOBULIN F(AB) FRAGMENT;
IMMUNOSUPPRESSIVE AGENT;
MONOCLONAL ANTIBODY;
PACLITAXEL;
PEPTIDE;
PEPTIDE FRAGMENT;
RAPAMYCIN;
RECOMBINANT PROTEIN;
TIROFIBAN;
TYROSINE;
AGED;
ARTICLE;
COMPARATIVE STUDY;
CORONARY ARTERY ATHEROSCLEROSIS;
COST;
DRUG ANTAGONISM;
DRUG COMBINATION;
DRUG DELIVERY SYSTEM;
ECONOMICS;
FEMALE;
HEART INFARCTION;
HUMAN;
LENGTH OF STAY;
MALE;
MIDDLE AGED;
RETROSPECTIVE STUDY;
STENT;
TREATMENT OUTCOME;
AGED;
ANTIBODIES, MONOCLONAL;
ANTICOAGULANTS;
CORONARY ARTERIOSCLEROSIS;
COSTS AND COST ANALYSIS;
DRUG DELIVERY SYSTEMS;
DRUG THERAPY, COMBINATION;
FEMALE;
HEPARIN;
HIRUDINS;
HUMANS;
IMMUNOGLOBULIN FAB FRAGMENTS;
IMMUNOSUPPRESSIVE AGENTS;
LENGTH OF STAY;
MALE;
MIDDLE AGED;
MYOCARDIAL INFARCTION;
PACLITAXEL;
PEPTIDE FRAGMENTS;
PEPTIDES;
PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX;
RECOMBINANT PROTEINS;
RETROSPECTIVE STUDIES;
SIROLIMUS;
STENTS;
TREATMENT OUTCOME;
TYROSINE;
|
EID: 33847281064
PISSN: None
EISSN: 15572501
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (5)
|
References (0)
|